End Cash: The amount of cash held by the company for the given period.
Vanda Pharmaceuticals Inc. (VNDA) had End Cash of $81.45M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$52.59M |
|
$-27.21M |
|
$2.74M |
|
$49.85M |
|
$91.09M |
|
$-38.50M |
|
$3.62M |
|
$-34.89M |
|
$-34.89M |
|
$-27.21M |
|
$-27.21M |
|
$-27.21M |
|
$-27.21M |
|
$-38.50M |
|
$-37.04M |
|
58.99M |
|
58.99M |
|
$-0.46 |
|
$-0.46 |
|
| Balance Sheet Financials | |
$394.92M |
|
$2.42M |
|
$229.82M |
|
$624.75M |
|
$121.49M |
|
$3.08M |
|
$16.93M |
|
$138.42M |
|
$486.33M |
|
$375.74M |
|
$486.33M |
|
59.08M |
|
| Cash Flow Statement Financials | |
$-48.40M |
|
$28.63M |
|
$-1.75M |
|
$102.78M |
|
|
End Cash |
$81.45M |
$-21.33M |
|
$5.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.25 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
94.80% |
|
-73.21% |
|
-73.21% |
|
-- |
|
-66.34% |
|
-51.73% |
|
$-49.13M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
1.26 |
|
1.17 |
|
77.00 |
|
-5.59% |
|
-7.24% |
|
-4.35% |
|
-5.56% |
|
$8.23 |
|
$-0.83 |
|
$-0.82 |
|